BackClarity Pharmaceuticals Overview

Clarity Pharmaceuticals Total Liabilities

Latest total liabilities for CU6.AX: $13M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$12.96M
↑ 18.41% YoYΔ $2.01M vs prior year quarter

Peer trimmed avg / median

Loading

Clarity Pharmaceuticals Total Liabilities History

Loading

Clarity Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Clarity Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clarity Pharmaceuticals (CU6.AX) FAQ

As of the most recent data (June 2026), CU6.AX shows a total liabilities of $13M. That compares with $11M in the prior-year period — up 18.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CU6.AX's total liabilities is now $13M (was $11M) — a 18.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clarity Pharmaceuticals is outperforming or lagging.

Tracking CU6.AX's total liabilities over time shows whether Clarity Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $11M in the prior-year period — up 18.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Clarity Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $13M) with ownership activity and broader fundamentals.

Questions & Answers